title: Dutch guidelines for diagnosis and treatment of chronic lymphocytic leukaemia 2011.
abstract: One of the principal responsibilities of the Chronic Lymphocytic Leukaemia (CLL) Working Party of the Dutch/Belgium Haemato-Oncology Foundation for Adults in the Netherlands (HOVON) is to create up-to-date guidelines for CLL . In this article, the revised guidelines for diagnosis and treatment are summarised. Despite recent expansion in treatment options for patients with CLL , the disease remains incurable in most cases and the optimal treatment approach for several subgroups of patients is still unclear. Therefore, it remains highly important to treat patients within clinical studies as much as possible. In this article, the current studies initiated by the HOVON CLL working party are emphasised.
authors: Department of Hematology, Academic Medical Center, Amsterdam, the Netherlands. a.p.kater@amc.nl
authors: A P
authors: AP
authors: Kater
authors: S
authors: S
authors: Wittebol
authors: M E D
authors: ME
authors: Chamuleau
authors: M
authors: M
authors: van Gelder
authors: M H
authors: MH
authors: J van Oers
authors: Hovon CLL Working Party
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis* / Q000628:therapy*; D009426:Netherlands; D012008:Recurrence
chemical_list: D000970:Antineoplastic Agents